PAIs are typically conducted by investigators from the FDA's Office of Regulatory Affairs (ORA).

What happens if significant deficiencies are found during a PAI?

Significant deficiencies can result in a 'refusal to approve' letter for the PMA application, requiring the manufacturer to address all issues before resubmission and potential re-inspection.

Is a PAI always required for a PMA application?

While not every PMA requires a PAI, the FDA routinely conducts them for novel or complex Class III devices, especially when manufacturing new processes or facilities are involved.

All terms

ManufacturingRegulated Pathways Global Markets Manufacturing & SupplyPAI

Pre-Approval Inspection

FDA inspection of a manufacturing facility prior to PMA approval.

Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed May 5, 2026

Definition

A Pre-Approval Inspection assesses whether the manufacturing site, processes, and quality systems are in a state of control sufficient to support PMA approval. FDA inspects the manufacturing sites named in a PMA, usually during the review, and approval depends on a satisfactory result. Investigators check that the quality system meets Part 820 and that the device can be made consistently to the specifications in the application. Observations are recorded on Form FDA 483 and must be resolved before approval.

What the regulation says

The FDA conducts Pre-Approval Inspections (PAIs) to determine if a medical device manufacturer is in compliance with Quality System Regulation (21 CFR Part 820) and if the data submitted in a Premarket Approval (PMA) application is accurate and complete. These inspections are a critical step before granting market authorization for Class III devices, as outlined in FDA guidance documents on PMA applications.

What this means in practice

PAI findings can delay or block PMA approvals. They also give FDA an early view into manufacturing capability.

Examples

A manufacturer of a novel implantable cardiac device undergoes a PAI where FDA investigators observe the sterile manufacturing environment and review sterilization validation records.
During a PAI for a new diagnostic imaging system, auditors verify the calibration of production equipment and interview quality control personnel about their procedures.
An audit team conducts a PAI at a contract manufacturer

Common pitfalls

•A common pitfall is underestimating the thoroughness of a PAI, assuming that only documentation will be reviewed, when in fact direct observation of manufacturing processes and employee interviews are standard.
•Another mistake is neglecting to conduct a comprehensive internal audit or mock PAI prior to the actual inspection, which can reveal weaknesses in the quality system.
•Failing to adequately address issues identified during previous inspections or internal audits can lead to significant PAI findings and delays.
•Inadequate training records or demonstration of employee competency often lead to PAI deficiencies, as these are direct indicators of a controlled manufacturing environment.
•Not having clear, well-documented, and consistently followed procedures for all aspects of manufacturing and quality control can result in immediate PAI issues.

Frequently asked questions

The primary purpose of a PAI is to verify that a medical device manufacturer can reliably produce a device according to its specifications and in compliance with the Quality System Regulation.

Cross-references

Used by

Things that build on this term.

Premarket Approval(PMA)

Grouped by theme

Editor's picks

· Hand-selected related concepts

Regulatory

Premarket Approval(PMA)

FDA's most stringent device marketing application, required for high-risk Class III devices.

Quality & Risk

Quality System Regulation(QSR / 21 CFR 820)

FDA's current good manufacturing practice (cGMP) requirements for medical devices.

More in Manufacturing

· Same category

Manufacturing

Bill of Materials(BOM)

Structured list of every component, sub-assembly, and quantity needed to manufacture a device.

Manufacturing

Bioburden

Quantification of viable microorganisms on or in a product before sterilization.

Manufacturing

Cleanroom Classes (ISO 14644)

ISO 14644 classification of cleanrooms by airborne particulate cleanliness (ISO 1 through ISO 9).

Manufacturing

Container Closure Integrity(CCI)

Demonstration that a sterile package maintains microbial barrier and contents integrity over the labeled shelf life.

Cited by

Where this term appears across MedTech Terms.

Ecosystems (3)

Latest in MedTech

Sources

3 sources

Sources support the definition or relevant regulatory context, not necessarily every claim on this page. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

Tier 2Regulator guidance and consensus· 3

Link health: 3 verified· last checked 2026-06-20

FDA·2IMDRF/GHTF·1

Inline markers like [1] jump to the matching reference above.

My progress

All terms0 / 513

Manufacturing0 / 22

Saved on this device, and to your account when signed in. View studied terms

Full glossary

Browse all terms A to Z, each with a short definition.

On this term

Category: Manufacturing
Acronym: PAI
Sources: 3
Updated: 5/5/2026

Compare with another term

Learn in 60 seconds

FDA inspection of a manufacturing facility prior to PMA approval.

·PAI findings can delay or block PMA approvals.
·They also give FDA an early view into manufacturing capability.
·FDA inspects the manufacturing sites named in a PMA, usually during the review, and approval depends on a satisfactory result.

Remember this

Watch out: A common pitfall is underestimating the thoroughness of a PAI, assuming that only documentation will be reviewed, when in fact direct observation of manufacturing processes and employee interviews are standard.

Related terms

You may also need

Auto-suggested from Manufacturing and shared keywords.

All Manufacturing terms